No connection

Search Results

Analysis Neutral

Evotec Nominates Dieter Weinand As Supervisory Board Chairman

Apr 07, 2026 05:58 UTC

April 07, 2026 — 01:58 am EDT Written byRTTNews.comforRTTNews-> (RTTNews) - Evotec SE (EVO, EVOTF), a German-based drug discovery and development company, on Tuesday announced that it has proposed the election of Dieter

  • April 07, 2026 — 01:58 am EDT Written byRTTNews
  • comforRTTNews-> (RTTNews) - Evotec SE (EVO, EVOTF), a German-based drug discovery and development company, on Tuesday announced that it has proposed the election of Dieter Weinand as Chairman of the Supervisory Board at its Annual General Meeting scheduled for June 11
  • Dieter Weinand is set to take over Iris Löw-Friedrich, whose term as Chairwoman will conclude at the end of the 2026 Annual General Meeting as part of a planned succession process

April 07, 2026 — 01:58 am EDT Written byRTTNews.comforRTTNews-> (RTTNews) - Evotec SE (EVO, EVOTF), a German-based drug discovery and development company, on Tuesday announced that it has proposed the election of Dieter Weinand as Chairman of the Supervisory Board at its Annual General Meeting scheduled for June 11. Dieter Weinand is set to take over Iris Löw-Friedrich, whose term as Chairwoman will conclude at the end of the 2026 Annual General Meeting as part of a planned succession process. Weinand brings more than 30 years of experience in the global pharmaceutical industry. Weinand previo

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile